BIONET Corp. (TPEX:1784)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
76.00
+1.50 (2.01%)
Apr 28, 2026, 1:30 PM CST
8.57%
Market Cap 3.82B
Revenue (ttm) 1.24B
Net Income (ttm) 51.43M
Shares Out 50.31M
EPS (ttm) 1.02
PE Ratio 74.51
Forward PE n/a
Dividend 1.42 (1.90%)
Ex-Dividend Date Oct 1, 2026
Volume 75,561
Average Volume 196,492
Open 74.50
Previous Close 74.50
Day's Range 74.50 - 76.00
52-Week Range 63.40 - 118.00
Beta 0.67
RSI 36.40
Earnings Date May 12, 2026

About BIONET

BIONET Corp. engages in the cell therapy business in Taiwan and internationally. The company offers stem cell banking services, such as stem cell storage, mesenchymal stem cell storage, dental stem cell storage, adipose stem cell, and PBSC and immune cells; and genetic testing services. It also provides storage and application of hematopoietic stem cells; regenerative medicine, analytical testing, clinical and preclinical research, and commercialized cell-derived products; and Exosome, a cell-free therapy. The company was founded in 1989 and is... [Read more]

Sector Healthcare
Founded 1989
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 1784
Full Company Profile

Financial Performance

In 2025, BIONET's revenue was 1.24 billion, an increase of 1.19% compared to the previous year's 1.22 billion. Earnings were 51.43 million, a decrease of -38.56%.

Financial Statements

News

There is no news available yet.